BLL Stock Recent News
BLL LATEST HEADLINES
WESTMINSTER, Colo. , May 22, 2025 /PRNewswire/ -- Ball Corporation (NYSE: BALL) today announced that Howard Yu, the company's chief financial officer, will be stepping down from his role effective June 30, 2025, pursuant to a mutual agreement.
Vancouver, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled "Gazing Through the Crystal Ball." The event is scheduled for May 21, 2025, at 12:00 PM ET (9:00 AM PT) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing FDA policies and political climates.
WESTMINSTER, Colo. , May 12, 2025 /PRNewswire/ -- Ball Corporation ("Ball") (NYSE: BALL) announced today that it priced an underwritten public offering of €850 million aggregate principal amount of 4.250% Senior Notes due 2032 (the "Notes").
[12/05/2025] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [Ball Corporation] Pre-stabilisation Period Announcement BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222 hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).
WESTMINSTER, Colo. , May 12, 2025 /PRNewswire/ -- Ball Corporation ("Ball") (NYSE: BALL) announced today that it has commenced an underwritten public offering of €750 million aggregate principal amount of Senior Notes due 2032 (the "Notes").
BALL's Q1 results reflect gains from higher volumes and price/mix across all segments.
Ball Corporation (NYSE:BALL ) Q1 2025 Earnings Conference Call May 6, 2025 11:00 AM ET Company Participants Brandon Potthoff - Director of Investor Relations Dan Fisher - Chief Executive Officer Howard Yu - Chief Financial Officer & Executive Vice President Conference Call Participants Ghansham Panjabi – Baird Stefan Diaz - Morgan Stanley Anthony Pettinari - Citi Phil Ng - Jefferies Edlain Rodriguez – Mizuho Josh Spector - UBS George Staphos - Bank of America Jeffrey Zekauskas - J.P. Morgan Michael Roxland - Truist Chris Parkinson - Wolfe Research Arun Viswanathan - RBC Operator Greetings, and welcome to the Ball Corporation First Quarter 2025 Earnings Conference Call.
Although the revenue and EPS for Ball (BALL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ball (BALL) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.68 per share a year ago.
Highlights First quarter U.S. GAAP total diluted earnings per share of 63 cents vs. $11.61 in 2024 First quarter comparable diluted earnings per share of 76 cents vs.